Hey, Respert. "I think it's fair to say that t
Post# of 158125
"I think it's fair to say that the ICIs are already a part of the trial in the rollover study, so any talk of "inclusion", at least to me, means getting them into the main part of the study. Which would be fantastic."
It was at the very end as one of the milestones/goals bullet points on the slide:
" - mCRC protocol submission to FDA regarding inclusion and timing of ICIs in current Phase II mCRC trial [4Q calendar 2025] "
Nice to see they're getting it over there this quarter, wouldn't be surprised if the FDA already has it.

